tiprankstipranks
Tenaya announces publication of TN-401 gene therapy preclinical data
PremiumThe FlyTenaya announces publication of TN-401 gene therapy preclinical data
1M ago
TNYA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
TNYA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
Tenaya Therapeutics to Participate in Upcoming March Investor Conferences
PremiumPress Releases
Tenaya Therapeutics to Participate in Upcoming March Investor Conferences
2M ago
Tenaya Therapeutics prices 8.89M shares at $4.50 in underwritten offering
PremiumThe FlyTenaya Therapeutics prices 8.89M shares at $4.50 in underwritten offering
3M ago
Tenaya Therapeutics 8.888M share Secondary priced at $4.50
PremiumThe Fly
Tenaya Therapeutics 8.888M share Secondary priced at $4.50
3M ago
Tenaya Therapeutics Announces Pricing of Underwritten Offering
PremiumPress Releases
Tenaya Therapeutics Announces Pricing of Underwritten Offering
3M ago
Tenaya Therapeutics price target raised to $19 from $17 at Canaccord
PremiumThe FlyTenaya Therapeutics price target raised to $19 from $17 at Canaccord
6M ago
Tenaya Therapeutics reports Q3 EPS (39c), consensus (47c)
PremiumThe Fly
Tenaya Therapeutics reports Q3 EPS (39c), consensus (47c)
6M ago
Tenaya Therapeutics announces FDA clearance to begin testing of TN-401
PremiumThe Fly
Tenaya Therapeutics announces FDA clearance to begin testing of TN-401
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100